
Melissa Jean Perreira
Examiner (ID: 10386, Phone: (571)272-1354 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1065 |
| Issued Applications | 491 |
| Pending Applications | 87 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9383364
[patent_doc_number] => 20140086845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'METHOD FOR IMAGING A SITE OF ARTHRITIS IN AN ANIMAL'
[patent_app_type] => utility
[patent_app_number] => 14/116711
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11827
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116711
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116711 | Method for imaging a site of arthritis in an animal | May 8, 2012 | Issued |
Array
(
[id] => 9369759
[patent_doc_number] => 20140079632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'ACTIVITY-BASED PROBES FOR THE UROKINASE PLASMINOGEN ACTIVATOR'
[patent_app_type] => utility
[patent_app_number] => 14/115449
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22482
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14115449
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/115449 | ACTIVITY-BASED PROBES FOR THE UROKINASE PLASMINOGEN ACTIVATOR | May 8, 2012 | Abandoned |
Array
(
[id] => 9537082
[patent_doc_number] => 20140161730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'MAGNETIC GRAPHENE-LIKE NANOPARTICLES OR GRAPHITIC NANO- OR MICROPARTICLES AND METHOD OF PRODUCTION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/116102
[patent_app_country] => US
[patent_app_date] => 2012-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 24083
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116102
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116102 | Magnetic graphene-like nanoparticles or graphitic nano- or microparticles and method of production and uses thereof | May 6, 2012 | Issued |
Array
(
[id] => 12226693
[patent_doc_number] => 09913921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-13
[patent_title] => 'Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a diene'
[patent_app_type] => utility
[patent_app_number] => 14/115455
[patent_app_country] => US
[patent_app_date] => 2012-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 24
[patent_no_of_words] => 26761
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14115455
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/115455 | Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a diene | May 6, 2012 | Issued |
Array
(
[id] => 8336138
[patent_doc_number] => 20120202839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 13/450102
[patent_app_country] => US
[patent_app_date] => 2012-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22981
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13450102
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/450102 | METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS | Apr 17, 2012 | Abandoned |
Array
(
[id] => 12367275
[patent_doc_number] => 09957293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses
[patent_app_type] => utility
[patent_app_number] => 13/447825
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 82
[patent_no_of_words] => 34339
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 596
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13447825
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/447825 | Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses | Apr 15, 2012 | Issued |
Array
(
[id] => 8324482
[patent_doc_number] => 20120196893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'COMPOSITION, METHOD, SYSTEM AND KIT FOR OPTICAL ELECTROPHYSIOLOGY'
[patent_app_type] => utility
[patent_app_number] => 13/442407
[patent_app_country] => US
[patent_app_date] => 2012-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15408
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13442407
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/442407 | Composition, method, system and kit for optical electrophysiology | Apr 8, 2012 | Issued |
Array
(
[id] => 8301987
[patent_doc_number] => 20120184545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'HEART-SLOWING DRUG CONTAINING SHORT-ACTING BETA-BLOCKER AS TEH ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 13/432160
[patent_app_country] => US
[patent_app_date] => 2012-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4665
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13432160
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/432160 | HEART-SLOWING DRUG CONTAINING SHORT-ACTING BETA-BLOCKER AS TEH ACTIVE INGREDIENT | Mar 27, 2012 | Abandoned |
Array
(
[id] => 9206191
[patent_doc_number] => 20140005369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'URIDINE-BASED GADOLINIUM COMPLEX AND MRI CONTRAST AGENT INCLUDING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/004831
[patent_app_country] => US
[patent_app_date] => 2012-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7657
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004831
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/004831 | Uridine-based gadolinium complex and MRI contrast agent including the same | Mar 14, 2012 | Issued |
Array
(
[id] => 8279588
[patent_doc_number] => 20120173463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'METHOD FOR INFORMING A PURCHASER OF A TOPICAL SKIN CARE PREPARATION OF AN OXIDATIVE STRESS PROTECTIVE CAPACITY'
[patent_app_type] => utility
[patent_app_number] => 13/420670
[patent_app_country] => US
[patent_app_date] => 2012-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5635
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13420670
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/420670 | METHOD FOR INFORMING A PURCHASER OF A TOPICAL SKIN CARE PREPARATION OF AN OXIDATIVE STRESS PROTECTIVE CAPACITY | Mar 14, 2012 | Abandoned |
Array
(
[id] => 9223831
[patent_doc_number] => 20140018606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'COMPOUNDS AND METHODS OF USE IN ABLATIVE RADIOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/003283
[patent_app_country] => US
[patent_app_date] => 2012-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8130
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003283
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/003283 | Compounds and methods of use in ablative radiotherapy | Mar 8, 2012 | Issued |
Array
(
[id] => 8759531
[patent_doc_number] => 08420049
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-16
[patent_title] => 'Labeled adenosine for use in positron emission tomography'
[patent_app_type] => utility
[patent_app_number] => 13/399642
[patent_app_country] => US
[patent_app_date] => 2012-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4571
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13399642
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/399642 | Labeled adenosine for use in positron emission tomography | Feb 16, 2012 | Issued |
Array
(
[id] => 9383927
[patent_doc_number] => 20140087409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'NEAR-INFRARED SILVER SULFIDE QUANTUM DOT, PREPARATION METHOD THEREFOR AND BIOLOGICAL APPLICATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/985731
[patent_app_country] => US
[patent_app_date] => 2012-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4133
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985731
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/985731 | NEAR-INFRARED SILVER SULFIDE QUANTUM DOT, PREPARATION METHOD THEREFOR AND BIOLOGICAL APPLICATION THEREOF | Feb 9, 2012 | Abandoned |
Array
(
[id] => 8312528
[patent_doc_number] => 20120189551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'MRI Markers, Delivery and Extraction Systems, and Methods of Manufacture and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/355229
[patent_app_country] => US
[patent_app_date] => 2012-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 25608
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13355229
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/355229 | MRI markers, delivery and extraction systems, and methods of manufacture and use thereof | Jan 19, 2012 | Issued |
Array
(
[id] => 8171215
[patent_doc_number] => 20120107250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'ABUSE-PROOFED DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 13/346257
[patent_app_country] => US
[patent_app_date] => 2012-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10899
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20120107250.pdf
[firstpage_image] =>[orig_patent_app_number] => 13346257
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/346257 | Abuse-proofed dosage form | Jan 8, 2012 | Issued |
Array
(
[id] => 8277250
[patent_doc_number] => 20120171119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'PEGYLATED FLUOROBENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING'
[patent_app_type] => utility
[patent_app_number] => 13/344084
[patent_app_country] => US
[patent_app_date] => 2012-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9654
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13344084
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/344084 | Pegylated fluorobenzamide analogues, their synthesis and use in diagnostic imaging | Jan 4, 2012 | Issued |
Array
(
[id] => 10534864
[patent_doc_number] => 09260483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-16
[patent_title] => 'Triazacyclononane-based phosphinate ligand and its use for molecular imaging'
[patent_app_type] => utility
[patent_app_number] => 13/978859
[patent_app_country] => US
[patent_app_date] => 2012-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 9237
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978859
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978859 | Triazacyclononane-based phosphinate ligand and its use for molecular imaging | Jan 4, 2012 | Issued |
Array
(
[id] => 9093650
[patent_doc_number] => 20130272961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'RADIOIODINATED GUANIDINES'
[patent_app_type] => utility
[patent_app_number] => 13/995528
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6731
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995528
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/995528 | RADIOIODINATED GUANIDINES | Dec 19, 2011 | Abandoned |
Array
(
[id] => 11197287
[patent_doc_number] => 09427482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-30
[patent_title] => 'Agents for clearing biomolecules from circulation'
[patent_app_type] => utility
[patent_app_number] => 13/994783
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 29412
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994783
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/994783 | Agents for clearing biomolecules from circulation | Dec 15, 2011 | Issued |
Array
(
[id] => 9211585
[patent_doc_number] => 20140010762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'IMAGING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/994835
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17116
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994835
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/994835 | IMAGING AGENTS | Dec 15, 2011 | Abandoned |